You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
McKinsey
Medtronic
McKesson
Colorcon

Last Updated: February 23, 2024

Lanthanum carbonate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for lanthanum carbonate and what is the scope of patent protection?

Lanthanum carbonate is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Barr, Invagen Pharms, and Natco Pharma Ltd, and is included in five NDAs. There are four patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Lanthanum carbonate has ninety-one patent family members in thirty-one countries.

There are nine drug master file entries for lanthanum carbonate. Six suppliers are listed for this compound.

Drug Prices for lanthanum carbonate

See drug prices for lanthanum carbonate

Recent Clinical Trials for lanthanum carbonate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Medical University of LodzPhase 4
Medical Universtity of LodzPhase 4
Universitair Ziekenhuis BrusselPhase 3

See all lanthanum carbonate clinical trials

Pharmacology for lanthanum carbonate
Drug ClassPhosphate Binder
Mechanism of ActionPhosphate Chelating Activity
Paragraph IV (Patent) Challenges for LANTHANUM CARBONATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FOSRENOL Oral Powder lanthanum carbonate 750 mg and 1000 mg 204734 1 2015-11-25
FOSRENOL Chewable Tablet lanthanum carbonate 500 mg, 750 mg and 1000 mg 021468 3 2008-10-27

US Patents and Regulatory Information for lanthanum carbonate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Usa FOSRENOL lanthanum carbonate POWDER;ORAL 204734-001 Sep 24, 2014 RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Natco Pharma Ltd LANTHANUM CARBONATE lanthanum carbonate TABLET, CHEWABLE;ORAL 090978-003 Aug 11, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Barr LANTHANUM CARBONATE lanthanum carbonate TABLET, CHEWABLE;ORAL 090977-001 Jan 27, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Invagen Pharms LANTHANUM CARBONATE lanthanum carbonate TABLET, CHEWABLE;ORAL 206868-001 Jan 24, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Natco Pharma Ltd LANTHANUM CARBONATE lanthanum carbonate TABLET, CHEWABLE;ORAL 090978-002 Aug 11, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for lanthanum carbonate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Takeda Pharms Usa FOSRENOL lanthanum carbonate POWDER;ORAL 204734-002 Sep 24, 2014 ⤷  Try a Trial ⤷  Try a Trial
Takeda Pharms Usa FOSRENOL lanthanum carbonate POWDER;ORAL 204734-001 Sep 24, 2014 ⤷  Try a Trial ⤷  Try a Trial
Takeda Pharms Usa FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-001 Oct 26, 2004 ⤷  Try a Trial ⤷  Try a Trial
Takeda Pharms Usa FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-003 Nov 23, 2005 ⤷  Try a Trial ⤷  Try a Trial
Takeda Pharms Usa FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-004 Nov 23, 2005 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for lanthanum carbonate

Country Patent Number Title Estimated Expiration
Eurasian Patent Organization 012798 ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ, СОДЕРЖАЩИЙ КАРБОНАТ ЛАНТАНА (ВАРИАНТЫ) (PHARMACEUTICAL FORMULATION COMPRISING LANTHANUM COMPOUND) ⤷  Try a Trial
Japan 2010248247 PHARMACEUTICAL FORMULATION COMPRISING LANTHANUM COMPOUND ⤷  Try a Trial
Japan 2020063292 ランタン化合物を含むカプセル製剤及び粉末製剤 (CAPSULE AND POWDER FORMULATIONS CONTAINING LANTHANUM COMPOUNDS) ⤷  Try a Trial
Portugal 2792363 ⤷  Try a Trial
Denmark 2172205 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Colorcon
Harvard Business School
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.